Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Synovis/Pegasus

This article was originally published in The Gray Sheet

Executive Summary

St. Paul, Minn., company announces $12.1 million acquisition of soft tissue repair device-maker Pegasus is complete on July 21. Synovis makes implantable biomaterials for soft tissue repair and microsurgery and surgical tools. The deal gives Synovis two equine pericardial-based technologies, the OrthADAPT bioimplant, cleared for surgical applications, and Unite biomatrix, indicated for treatment of chronic wounds. Synovis has so far hired 25 of Pegasus' 75 employees and retains Pegasus' Irvine, Calif., manufacturing operation as a separate division
Advertisement
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT027719

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel